APPLICATIONS PUBLISHED 17 JULY 2002

Published: 1-Jan-2003

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Hybrid matrices and hybrid matrix mixtures
    Transkaryotic Therapies 1221937*

  • Method for producing liposome preparation
    Fujisawa Pharmaceutical 1221938*

  • Ortho ester lipids
    The Regents of the University of California 1221939*

  • Powder pharmaceutical formulations
    WM Wrigley 1221941*

  • Biodegradable microparticles with novel erythropoietin stimulating protein
    Amgen 1221942*

  • Method of producing sub-micron particles of biologically active agents
    Alkermes Controlled Therapeutics 1221943*

  • Oral dosage form comprising a salt of morphine or a morphine derivative
    Alkaloid 1221944*

  • Methods, pharmaceutical and therapeutic compsns for administering adenosine
    Rapaport, Eliezer 1221945*

  • Targeted drug activation
    Yarmut, Yehuda 1221946*

  • Soft gel capsule resistant to gastric juices
    Natco Pharma 1221947*

  • Use of compsns for the caring treatment of the skin
    Henkel 1221948*

  • Method and compsn for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses
    Procter & Gamble 1221949*

  • Synergistic combinations of an NK1 receptor antagonist and a GABA structural analogue
    Warner-Lambert 1221950*

  • Treatment of pancreatic disease
    Peplin Research 1221951*

  • Use of central cannabinoid receptor anagonist for preparing medicines
    Sanofi-Synthelabo 1221952*

  • Treating sleep disorders using desloratadine
    Schering Corp 1221953*

  • Methods for identifying inhibitors of methionne aminopeptidases
    Saint Louis University 1221954*

  • Immunostimulatory nucleic acids
    University of Iowa Research Foundation 1221955*

  • Autologous marrow stem cell (MSC) transplantation for myocardial regeneration
    McGill University 1221956*

  • Analgesic from snake venom
    SIS Shulov Institute for Science 1221958*

  • Use of parvoviruses for improving the general condition of tumour patients or patients having chronic or consumptive diseases
    Von Knebel Doeberitz 1221959*

  • Use of mushroom spawn as a supplement or support for therapeutic nutritional or micronutritional formulations in order to potentiate their effect
    Sante Nutrition Selection Diffusion 1221960*

  • Induction of a strong immune response to a self-tumour associated antigen
    Roswell Park Memorial Institute 1121961*

  • Inhibitors of proteosomal activity for stimulating bone and hair growth
    Osteoscreen 1221962*

  • Methods of inhibiting osteoclastogenesis
    The Trustees of the University of Pennsylvania 1221963*

  • Antigenic modification of polypeptides
    The Ohio State University Research Foundation 1221964*

  • Use of TGF beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa
    NV Nutricia 1221965*

  • Method for reducing the risk of cancer
    Eli Lilly 1221966*

  • Highly efficient dendritic cell-targeted DNA-vaccination
    Brocker, Thomas 1221967*

  • Method of obtaining cellular immune responses from proteins
    Chiron 1221968*

  • Activation of antigen-specific T cells by virus/antigen-treated dendritic cells
    Ahlert, Thorsten 1221969*

  • Compsns and methods for stimulating an immune response against infectious agents
    Chiron 1221970*

  • Use of the combination of polyoxyethylene sorbitan ester and ocytoxynol as adjuvant and its use in vaccines
    SmithKline Beecham Biologicals 1221971*

  • Plant lectins as mucosal adjuvants
    Chiron 1221972*

  • CD40 antagonist for treating psoriasis
    Chiron Corp 1221973*

  • Polymer stabilised neuropeptides
    Shearwater Corp 1221975*

  • Technetium TC99M teboroxime myocardial perfusion agent
    Bracco Diagnostic 1221978*

  • Intermediates for making an benzofuran or benzothiophene derivative nitrated in position 5 and uses thereof
    Rhodia Chimie 1222159*

  • Process for preparing a substituted allylamine derivative and the salts thereof
    Richter Gideon Vegyeszeti Gyar 1222160*

  • 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compound
    Aventis Pharma Deutschland 1222163*

  • Methods of asymmetrically synthesising enantiomers of Casodex, its derivatives and intermediates thereof
    Nobex Corp 1122165*

  • Methods for producing indole derivatives on a solid phase
    Merck Patent 1222167*

  • Novel trisubstituted pyridine compounds
    AstraZeneca 1222169*

  • Novel nicotinonitrile compounds
    AstraZeneca 1222170*

  • Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
    Torrent Pharmaceuticals 1222171*

  • Synthesis of 1,3,5-trisubstituted pyrazoles and intermediates therefore
    Bristol-Myers Squibb 1222172*

  • Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
    Aventis Cropscience 1222173*

  • Imidazol-4-ylmethanols use as inhibitors of steroid C17-20 lipase
    Takeda Chemical Industries 1222174*

  • 4,5-disubstituted-2-aminopyrimidines
    Celltech R&D 1222175*

  • Amino lactam sulphonamides as inhibitors of (b)-protein production
    Bristol-Myers Squibb 1222176*

  • Substituted aryl ketones
    Bayer 1222177*

  • Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
    ARYx Therapeutics 1222180*

  • Method for preparing a benzofuran or benzothiphene compound
    Rhodia Chemie 1222181*

  • Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
    Aventis Pharmaceuticals 1222182*

  • Benzopyran derivatives
    Recordati Industria Chimica e Farmaceutica 1222183*

  • Tetrahydrobenzinolone derivatives, their preparation and their use as 5-HT7 receptors antagonists
    SmithKline Beecham 1222185*

  • Condensed naphthyridines as HIV reverse transcriptase inhibitors
    Bristol-Myers Squibb Pharma 1222186*

  • Heterocyclic compounds useful as inhibitors of tyrosine kinases
    Boehringer Ingelheim Pharmaceuticals 1222187*

  • Novel imidazopyridine carbonitrile compounds
    AstraZeneca 1222188*

  • Benzodiazepin derivatives, the production and use thereof
    BASF 1222191*

  • Imidazole derivatives as phosphodiesterase VII inhibitors
    Merck Patent 1222193*

  • 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof
    Essential Therapeutics 1222194*

  • Novel thiazolo(4,5-d)pyrimidine compounds
    AstraZeneca 1222195*

  • You may also like